User
Information for Reviewer
Peer Review Process
Index

JKB telah terindex di Crossref JKB telah terindex di Google Scholar JKB telah terindex di SINTA Ristekdikti JKB telah terindex di Portal Garuda

Notifications
Journal Content

Browse
Visitor Counter

 

ANALISIS LOSS OF HETEROZYGOSITYGEN RAR β2 PADA PATOGENESIS KANKER PAYUDARA

I Ketut Gede Muliartha, Wibi Riawan, Asnah Hidayat, Fitri Armania
  Jurnal Kedokteran Brawijaya, Vol 24, No 2 (2008),    

Abstract


The aim of this research was to investigate the event of loss of heterozygosity of retinoid acid receptor (RAR β2) gene on the chromosom 3p24 in the pathogenesis ofbreast cancer. The breast cancer is the most malignant tumor that leads the second cause of death among the female. The recent concept of the theory of pathogenesis breast cancer is molecular genetic approaches such as apoptosis gene, oncogen, suppressorgene, and growth promoting factor gene. However, the diagnostic and therapy of breast cancer are still not satisfied. The lost or decreased in the expressionof RAR  β2gene on 3p24 chromosome via loss of heterozygosity (LOH) mechanism are the role of pathogenesis of breast cancer. Design of the research is by experimental and observational. Human female breastcancer and blood samples were gained from public hospital RSUD dr. Saiful Anwar, Malang. DNA was extracted from lymphocyte and tissue using Macherey-Nagel system kit. Loss of heterozygosity (LOH) incident in 3p24 chromosome was detected by PCR and Chromogenic in situ Hybridization (CISH) method.

Full Text:

PDF PDF

References


Deng G, Luy Zionikov G dan AD Smith AS. Loss of heterozygosity a normal tissue adjacert to breast carcinoma. Science, 1995; 274:2057-2059

Cotran, Robbins, R.L. dan Kumar, V. 1989, Pathology Basic of Disease: Breast Cancer, 4thedition, WB Saunders International Edition, Four Edition, 1989; 192-200.

Evans TRJ, Kayes. B. Retinoids present role and future BRJ Cancer. 1999;80:1-6.

Khramer, Digiovanna JJ, Peck GL. Chemoprevention of skin cancer xerodermal pigmentosom, J. Dermato. 1992, 1987; 715 – 718.

Lippman SM, lee JJ, Sabichi Al. Cancer chemoprevention progress and promise. J. Nati Cancer inst; 1998 ;85:1492 – 1498.

Liu X, Lee Mo, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JL, Zhang X. Retinoic acid by promoting apoptosis human breast cancer cells. Mo Cell Biol, 1996;6:1188 – 1149

Sirchia SM, Ferguson AT, Sironi E, Subramayan S, Orlandi R, Sukumar S, Sacchi N. evidence of epigenetic changes attecting the chromatin state

of the retinoic acid receptor beta 2 promoter n breast cancer cell oncogene. 2000;19:1556 – 1563

Gote S, sinrett D, Momparier RL. Demethylation by 5-aza 2 deoxy cytidine at specific 5-methylcytosine s les in the promoter region on the

retinoid acid receptor beta gene in human colon carcinoma cell antitumor drugs.19989:743 – 750

Kane MF, Loda M, Gaida GM Lipmann J, Mishra, Goldman – fassud JM Kolodner R. Methylation of the aMLH promoter correlated with lack of

expression of VLH a sporadic colon tumor and stomach detective human tumor cell cancer. res 1997; 57: 5556-5560

Knazer K, Vogeisteir B. Lesson from hereditary colorectal cancer cel.1996;87:159-192

Berard J, Laboune F, Mukuna M, Masse S, Khotary R, Bradey WE. Lung tumors in mice expressing an antisense RAR β2.Transgene Faseb. 1996; 10 - 09 – 1097.




DOI: http://dx.doi.org/10.21776/ub.jkb.2008.024.02.5

Refbacks

  • There are currently no refbacks.